A Kaplan Meier survival curve (Figure 5C) of untreated control mice compared to mice treated with the CCK-BR targeted NP loaded with GAST siRNA (480 nM) shows a significant survival benefit (p = 0.02) even in mice with a large tumor burden. Here, GAST is linked to neoplasm.